MLC Medical LLC has partnered with LG Chem, Ltd., the South Korean life sciences leader, to bring targeted biologic therapies to patients across Georgia.

Through this agreement, MLC Medical registers Eucept (Etanercept) prefilled syringes in both 25mg and 50mg strengths. As an established anti-TNF biologic agent, Eucept provides targeted therapeutic action for patients suffering from rheumatoid arthritis, ankylosing spondylitis, psoriasis, and related autoimmune conditions.

This launch underscores MLC Medical’s commitment to expanding local access to high-demand biologicals, enabling rheumatologists to offer dependable treatment plans backed by LG Chem’s manufacturing excellence.

MLC Medical is eager to build a lasting relationship with LG Chem and to deliver specialized biologic therapies that meaningfully improve patient outcomes.